we investigated the pathophysiology underlying defective bone mineralization in two individuals and examined the effects of 1,25-dihydroxyvitamin d ( 1,25 ( oh ) 2d , calcitriol ) therapy on the clinical and biochemical abnormalities .
C0012328
dihydroxyvitamin d
C0006674
calcitriol